clip170 Search Results


93
Addgene inc memeraldclip170 n 18
Memeraldclip170 N 18, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/memeraldclip170 n 18/product/Addgene inc
Average 93 stars, based on 1 article reviews
memeraldclip170 n 18 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology clip 170 shrna lentiviral particles
Clip 170 Shrna Lentiviral Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clip 170 shrna lentiviral particles/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
clip 170 shrna lentiviral particles - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Proteintech clip 170
Clip 170, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clip 170/product/Proteintech
Average 93 stars, based on 1 article reviews
clip 170 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology antibodies against clip 170
Antibodies Against Clip 170, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against clip 170/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
antibodies against clip 170 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Addgene inc small interfering rna sirna design
Fig. 2 TTL expression regulates Clip170 tension and breast cancer invasion and migration. A Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL <t>siRNA</t> or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group) (B) Left panel: 15-min time-lapse images of FRET analysis in MCF7 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group). C Representative CFP images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid. D Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with WT- Clip170 alone group). E Representative images of the migration and invasion of MDA-MB-468 cells in the control, TTL siRNA, TTL overexpression and TTL rescue groups. F Quantitative analysis of the migration and invasion cells (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with WT-Clip170 alone group).
Small Interfering Rna Sirna Design, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small interfering rna sirna design/product/Addgene inc
Average 93 stars, based on 1 article reviews
small interfering rna sirna design - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
Bethyl clip 170
Fig. 2 TTL expression regulates Clip170 tension and breast cancer invasion and migration. A Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL <t>siRNA</t> or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group) (B) Left panel: 15-min time-lapse images of FRET analysis in MCF7 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group). C Representative CFP images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid. D Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with WT- Clip170 alone group). E Representative images of the migration and invasion of MDA-MB-468 cells in the control, TTL siRNA, TTL overexpression and TTL rescue groups. F Quantitative analysis of the migration and invasion cells (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with WT-Clip170 alone group).
Clip 170, supplied by Bethyl, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clip 170/product/Bethyl
Average 90 stars, based on 1 article reviews
clip 170 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc 8977 predicted target genes
Fig. 2 TTL expression regulates Clip170 tension and breast cancer invasion and migration. A Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL <t>siRNA</t> or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group) (B) Left panel: 15-min time-lapse images of FRET analysis in MCF7 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group). C Representative CFP images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid. D Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with WT- Clip170 alone group). E Representative images of the migration and invasion of MDA-MB-468 cells in the control, TTL siRNA, TTL overexpression and TTL rescue groups. F Quantitative analysis of the migration and invasion cells (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with WT-Clip170 alone group).
8977 Predicted Target Genes, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8977 predicted target genes/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
8977 predicted target genes - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology clip 170
Fig. 2 TTL expression regulates Clip170 tension and breast cancer invasion and migration. A Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL <t>siRNA</t> or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group) (B) Left panel: 15-min time-lapse images of FRET analysis in MCF7 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group). C Representative CFP images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid. D Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with WT- Clip170 alone group). E Representative images of the migration and invasion of MDA-MB-468 cells in the control, TTL siRNA, TTL overexpression and TTL rescue groups. F Quantitative analysis of the migration and invasion cells (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with WT-Clip170 alone group).
Clip 170, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clip 170/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
clip 170 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
OriGene clip170
Fig. 2 TTL expression regulates Clip170 tension and breast cancer invasion and migration. A Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL <t>siRNA</t> or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group) (B) Left panel: 15-min time-lapse images of FRET analysis in MCF7 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group). C Representative CFP images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid. D Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with WT- Clip170 alone group). E Representative images of the migration and invasion of MDA-MB-468 cells in the control, TTL siRNA, TTL overexpression and TTL rescue groups. F Quantitative analysis of the migration and invasion cells (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with WT-Clip170 alone group).
Clip170, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clip170/product/OriGene
Average 90 stars, based on 1 article reviews
clip170 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology tmk1 cell lines
Fig. 2 TTL expression regulates Clip170 tension and breast cancer invasion and migration. A Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL <t>siRNA</t> or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group) (B) Left panel: 15-min time-lapse images of FRET analysis in MCF7 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group). C Representative CFP images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid. D Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with WT- Clip170 alone group). E Representative images of the migration and invasion of MDA-MB-468 cells in the control, TTL siRNA, TTL overexpression and TTL rescue groups. F Quantitative analysis of the migration and invasion cells (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with WT-Clip170 alone group).
Tmk1 Cell Lines, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tmk1 cell lines/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
tmk1 cell lines - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
Institut Curie clip-170 mt binding protein
Fig. 2 TTL expression regulates Clip170 tension and breast cancer invasion and migration. A Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL <t>siRNA</t> or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group) (B) Left panel: 15-min time-lapse images of FRET analysis in MCF7 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group). C Representative CFP images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid. D Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with WT- Clip170 alone group). E Representative images of the migration and invasion of MDA-MB-468 cells in the control, TTL siRNA, TTL overexpression and TTL rescue groups. F Quantitative analysis of the migration and invasion cells (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with WT-Clip170 alone group).
Clip 170 Mt Binding Protein, supplied by Institut Curie, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clip-170 mt binding protein/product/Institut Curie
Average 90 stars, based on 1 article reviews
clip-170 mt binding protein - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
IBA GmbH small interfering rnas ( 20 ) specific for the n-terminal portion of the cenp-a and clip-170 mrnas
Fig. 2 TTL expression regulates Clip170 tension and breast cancer invasion and migration. A Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL <t>siRNA</t> or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group) (B) Left panel: 15-min time-lapse images of FRET analysis in MCF7 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group). C Representative CFP images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid. D Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with WT- Clip170 alone group). E Representative images of the migration and invasion of MDA-MB-468 cells in the control, TTL siRNA, TTL overexpression and TTL rescue groups. F Quantitative analysis of the migration and invasion cells (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with WT-Clip170 alone group).
Small Interfering Rnas ( 20 ) Specific For The N Terminal Portion Of The Cenp A And Clip 170 Mrnas, supplied by IBA GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small interfering rnas ( 20 ) specific for the n-terminal portion of the cenp-a and clip-170 mrnas/product/IBA GmbH
Average 90 stars, based on 1 article reviews
small interfering rnas ( 20 ) specific for the n-terminal portion of the cenp-a and clip-170 mrnas - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 2 TTL expression regulates Clip170 tension and breast cancer invasion and migration. A Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group) (B) Left panel: 15-min time-lapse images of FRET analysis in MCF7 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group). C Representative CFP images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid. D Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with WT- Clip170 alone group). E Representative images of the migration and invasion of MDA-MB-468 cells in the control, TTL siRNA, TTL overexpression and TTL rescue groups. F Quantitative analysis of the migration and invasion cells (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with WT-Clip170 alone group).

Journal: Cell death & disease

Article Title: Tension of plus-end tracking protein Clip170 confers directionality and aggressiveness during breast cancer migration.

doi: 10.1038/s41419-022-05306-6

Figure Lengend Snippet: Fig. 2 TTL expression regulates Clip170 tension and breast cancer invasion and migration. A Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group) (B) Left panel: 15-min time-lapse images of FRET analysis in MCF7 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid after CXCL12 treatment. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to tension versus time, respectively. (Mean ± SEM, n ≥6 cells in each group). C Representative CFP images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe and transfected with the TTL siRNA or TTL overexpression plasmid. D Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with WT- Clip170 alone group). E Representative images of the migration and invasion of MDA-MB-468 cells in the control, TTL siRNA, TTL overexpression and TTL rescue groups. F Quantitative analysis of the migration and invasion cells (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with WT-Clip170 alone group).

Article Snippet: Plasmid construction and small interfering RNA (siRNA) design The mEmerald-CLIP170-C-18 (#54043) was purchased from Addgene (Watertown, MA, USA). pCMV3-TTL (HG23280-UT) and Pcmv3-FlagIQGAP2 plasmids were obtained from Sino Biological (Beijing, China).

Techniques: Expressing, Migration, Transfection, Over Expression, Plasmid Preparation, Control

Fig. 6 RSK promotes Clip170 tension and breast cancer aggressiveness. A Left panel: Representative images of FRET analysis of cells treated with the RSK inhibitor (BRD7389) for 0, 1, 3, and 6 h. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Mean CFP/FRET ratios for the whole cell. (mean ± SEM, n ≥6 cells in each group, **P < 0.01, ***P < 0.001 compared with 0h-treatment group). B Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells transfected with the Clip170-cpstFRET probe alone or combined with RSK siRNA. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to Clip170 tension versus time (mean ± SEM, n ≥5 cells in each group). C Left panel: Representative images of FRET analysis of MDA-MB-468 cells transfected with the Clip170-cpstFRET, Clip170-S-A-cpstFRET, Clip170-S-D-cpstFRET, Clip170-S311A-cpstFRET, or Clip170-S311D-cpstFRET probes treated with the RSK inhibitor (BRD7389) for 6 h. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Mean CFP/FRET ratios for the whole cell. (mean ± SEM, n ≥6 cells in each group, ***P < 0.001 compared with the cells without BRD7389 treatment). D Western blotting analysis of RSK-siRNA and RSK inhibitor treatment in MDA-MB-468 cells. E Western blotting analysis of RSK and p-RSK levels in MDA-MB-468, MCF7, and MDA-MB-231 after CXCL12 treatment. F Representative images of the migration and invasion of control, NC, RSK-siRNA, DMSO, and RSK inhibitor (BRD7389) treatment groups. G–H Quantitative analysis of the migration (G) and invasion (H) rates (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with NC or DMSO group). I Western blotting analysis of RSK and p-RSK levels in breast cancer tissue (situ) and adjacent normal tissue (para). J Quantitative analysis of the p-RSK/RSK ratio in breast cancer tissue and matched normal tissues (n = 10).

Journal: Cell death & disease

Article Title: Tension of plus-end tracking protein Clip170 confers directionality and aggressiveness during breast cancer migration.

doi: 10.1038/s41419-022-05306-6

Figure Lengend Snippet: Fig. 6 RSK promotes Clip170 tension and breast cancer aggressiveness. A Left panel: Representative images of FRET analysis of cells treated with the RSK inhibitor (BRD7389) for 0, 1, 3, and 6 h. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Mean CFP/FRET ratios for the whole cell. (mean ± SEM, n ≥6 cells in each group, **P < 0.01, ***P < 0.001 compared with 0h-treatment group). B Left panel: 15-min time-lapse images of FRET analysis in MDA-MB-468 cells transfected with the Clip170-cpstFRET probe alone or combined with RSK siRNA. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Normalized CFP/FRET signals for the whole cell corresponding to Clip170 tension versus time (mean ± SEM, n ≥5 cells in each group). C Left panel: Representative images of FRET analysis of MDA-MB-468 cells transfected with the Clip170-cpstFRET, Clip170-S-A-cpstFRET, Clip170-S-D-cpstFRET, Clip170-S311A-cpstFRET, or Clip170-S311D-cpstFRET probes treated with the RSK inhibitor (BRD7389) for 6 h. Calibration bar, 0.2–2.0; scale bar, 10 μm. Right panel: Mean CFP/FRET ratios for the whole cell. (mean ± SEM, n ≥6 cells in each group, ***P < 0.001 compared with the cells without BRD7389 treatment). D Western blotting analysis of RSK-siRNA and RSK inhibitor treatment in MDA-MB-468 cells. E Western blotting analysis of RSK and p-RSK levels in MDA-MB-468, MCF7, and MDA-MB-231 after CXCL12 treatment. F Representative images of the migration and invasion of control, NC, RSK-siRNA, DMSO, and RSK inhibitor (BRD7389) treatment groups. G–H Quantitative analysis of the migration (G) and invasion (H) rates (Mean ± SEM, n = 3 independent experiments and at least three fields, ***P < 0.001 compared with NC or DMSO group). I Western blotting analysis of RSK and p-RSK levels in breast cancer tissue (situ) and adjacent normal tissue (para). J Quantitative analysis of the p-RSK/RSK ratio in breast cancer tissue and matched normal tissues (n = 10).

Article Snippet: Plasmid construction and small interfering RNA (siRNA) design The mEmerald-CLIP170-C-18 (#54043) was purchased from Addgene (Watertown, MA, USA). pCMV3-TTL (HG23280-UT) and Pcmv3-FlagIQGAP2 plasmids were obtained from Sino Biological (Beijing, China).

Techniques: Transfection, Western Blot, Migration, Control

Fig. 7 IQGAP 1 location regulates cortactin-associated formation of filopodia and lamellipodia. A Representative images of MF and IQGAP1 or IQGAP2 distribution in the directional migration model or after CXCL12 treatment. (green, FITC-stained MFs; red, TRITC-stained IQGAP1/IQGAP2), scale bar, 10 μm. B Representative images of MF and IQGAP1 or IQGAP2 distribution in the wound healing assay. (green, FITC-stained MFs; red, TRITC-stained IQGAP1/IQGAP2), scale bar, 10 μm. C Western blotting analysis of Cortactin, IQGAP1, and IQGAP2 levels in the NC, IQGAP1-siRNA, IQGAP2-siRNA, and IQGAP2 and IQGAP2 rescue groups. D Western blotting analysis of cortactin levels in the WT, S311A, S311D, S-A, and S-D groups. E Western blotting analysis of cortactin levels in the control, NC, RSK- siRNA, and RSK inhibitor treatment groups. F Representative images of filopodia and lamellipodia structures in the Clip170 mutation, and NC, IQGAP1 and IQGAP2-siRNA groups (scale bar, 10 μm, green, FITC-stained MFs; blue, nucleus; white arrows: filopodia and lamellipodia structures).

Journal: Cell death & disease

Article Title: Tension of plus-end tracking protein Clip170 confers directionality and aggressiveness during breast cancer migration.

doi: 10.1038/s41419-022-05306-6

Figure Lengend Snippet: Fig. 7 IQGAP 1 location regulates cortactin-associated formation of filopodia and lamellipodia. A Representative images of MF and IQGAP1 or IQGAP2 distribution in the directional migration model or after CXCL12 treatment. (green, FITC-stained MFs; red, TRITC-stained IQGAP1/IQGAP2), scale bar, 10 μm. B Representative images of MF and IQGAP1 or IQGAP2 distribution in the wound healing assay. (green, FITC-stained MFs; red, TRITC-stained IQGAP1/IQGAP2), scale bar, 10 μm. C Western blotting analysis of Cortactin, IQGAP1, and IQGAP2 levels in the NC, IQGAP1-siRNA, IQGAP2-siRNA, and IQGAP2 and IQGAP2 rescue groups. D Western blotting analysis of cortactin levels in the WT, S311A, S311D, S-A, and S-D groups. E Western blotting analysis of cortactin levels in the control, NC, RSK- siRNA, and RSK inhibitor treatment groups. F Representative images of filopodia and lamellipodia structures in the Clip170 mutation, and NC, IQGAP1 and IQGAP2-siRNA groups (scale bar, 10 μm, green, FITC-stained MFs; blue, nucleus; white arrows: filopodia and lamellipodia structures).

Article Snippet: Plasmid construction and small interfering RNA (siRNA) design The mEmerald-CLIP170-C-18 (#54043) was purchased from Addgene (Watertown, MA, USA). pCMV3-TTL (HG23280-UT) and Pcmv3-FlagIQGAP2 plasmids were obtained from Sino Biological (Beijing, China).

Techniques: Migration, Staining, Wound Healing Assay, Western Blot, Control, Mutagenesis

Fig. 8 IQGAP1 and 2 are correlated in Clip170 tension magnitude and distribution. A Representative images of MDA-MB-468 expressing the Clip170-cpstFRET probe in the IQGAP1-siRNA, IQGAP2-siRNA, IQGAP2 overexpression, and IQGAP2 rescue groups. B Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in the different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with NC group). C Representative images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe in the IQGAP1-siRNA, IQGAP2-siRNA, IQGAP2 overexpression, and IQGAP2 rescue groups in the directional migration model, scale bar, 10 μm.

Journal: Cell death & disease

Article Title: Tension of plus-end tracking protein Clip170 confers directionality and aggressiveness during breast cancer migration.

doi: 10.1038/s41419-022-05306-6

Figure Lengend Snippet: Fig. 8 IQGAP1 and 2 are correlated in Clip170 tension magnitude and distribution. A Representative images of MDA-MB-468 expressing the Clip170-cpstFRET probe in the IQGAP1-siRNA, IQGAP2-siRNA, IQGAP2 overexpression, and IQGAP2 rescue groups. B Normalized CFP/FRET signals, comet lengths, comet quantities, and fluorescence intensities for the whole cell in the different groups (scale bar, 10 μm, n ≥6 cells in each group, ***P < 0.001 compared with NC group). C Representative images of MDA-MB-468 cells expressing the Clip170-cpstFRET probe in the IQGAP1-siRNA, IQGAP2-siRNA, IQGAP2 overexpression, and IQGAP2 rescue groups in the directional migration model, scale bar, 10 μm.

Article Snippet: Plasmid construction and small interfering RNA (siRNA) design The mEmerald-CLIP170-C-18 (#54043) was purchased from Addgene (Watertown, MA, USA). pCMV3-TTL (HG23280-UT) and Pcmv3-FlagIQGAP2 plasmids were obtained from Sino Biological (Beijing, China).

Techniques: Expressing, Over Expression, Migration